People whose CTLA4 checkpoint is blocked by antibody immunotherapy,126, 127, 128 or by germline mutations in the CTLA4 gene,129, 130, 131 often but not always develop severe gastrointestinal inflammatory disease and autoimmune diseases. Here, CTLA4 is linked to autoimmune disease.